Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Performance of HPV E6/E7 mRNA Genotyping Test on Paired Cervical Cancer Exfoliated Cells and Formalin Fixed Paraffin Embedded Tissues

  • Park, Sunyoung (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Wang, Hyeyoung (M&D, Inc., Wonju Eco Environmental Technology Center) ;
  • Kim, Sunghyun (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Geehyuk (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Bong, Sungyoung (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Jang, Hyoungsoon (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Park, Sangjung (Department of Biomedical Science, College of Life and Health Sciences, Hoseo University) ;
  • Hwang, Kooyeon (Department of Clinical Laboratory Science, Seoyeong University) ;
  • Lee, Dongsup (Department of Clinical Laboratory Science, Hyejeon College)
  • Received : 2016.09.04
  • Accepted : 2016.09.30
  • Published : 2016.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Investigation of human papillomavirus (HPV) in archival formalin-fixed paraffin-embedded (FFPE) material is important for understanding cervical carcinogenesis. The objective of the present study was to identify the high risk HPVs (HR-HPVs) using HPV E6/E7 mRNA testing from archival tissues in cervical cancer and the relation to HR-HPVs genotypes in paired cervical exfoliated cells. HPV E6/E7 mRNA testing and DNA chip testing were performed in 79 paired cervical FFPE tissues and exfoliated cells from women with histologically confirmed squamous cell carcinoma and adenocarcinoma. Overall agreement in HR-HPVs detection from FFPE samples and cytology samples were 98.5% in HPV 16, 100% in HPV 18, HPV 31, HPV 33, HPV 58, HPV 66, and HPV 68. Type-specific agreement between FFPE samples and cytology samples was 89.1% in HPV positive, 93.5% in HPV 16 and more than 70% in the other HR-HPVs. In conclusion, HR-HPVs were reliably detected in paired FFPE and cytology samples with some variation in type-specific detection.

Keywords

References

  1. Carozzi F, Ronco G, Confortini M, Noferini D, Maddau C, Ciatto S, Segnan N. Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. British Journal of Cancer. 2000. 83: 1462-1467. https://doi.org/10.1054/bjoc.2000.1491
  2. Carozzi M, Tornesello L, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro M, Rossi G, Grp W. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in italy. Cancer Epidemiology Biomarkers & Prevention. 2010. 19: 2389-2400. https://doi.org/10.1158/1055-9965.EPI-10-0131
  3. Castle E, Sadorra M, Garcia F, Holladay B, Kornegay J. Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol. 2006. 44: 3915-3917. https://doi.org/10.1128/JCM.01305-06
  4. Castro A, Koshiol J, Quint W, Wheeler M, Gillison L, Vaughan M, Kleter B, Van J, Chaturvedi K, Hildesheim A, Schiffman M, Wang S, Zuna E, Walker L, Dunn T, Wentzensen N. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. BMC Infect Dis. 2015. 15: 544. https://doi.org/10.1186/s12879-015-1281-5
  5. De sanjose S, Quint G, Alemany L, Geraets T, Klaustermeier E, Lloveras B, Tous S, Felix A, Bravo E, Shin R, Vallejos S, De ruiz A, Lima A, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng C, Tatti A, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez A, Lombardi E, Banjo A, Menendez C, Domingo J, Velasco J, Nessa A, Chichareon C, Qiao L, Lerma E, Garland M, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer J, Al-jassar F, Cruz E, Wright C, Puras A, Llave L, Tzardi M, Agorastos T, Garcia V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez I, Nowakowski M, Bornstein J, Munoz N, Bosch X. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010. 11: 1048-1056. https://doi.org/10.1016/S1470-2045(10)70230-8
  6. Dona G, Ronchetti L, Giuliani M, Carosi M, Rollo F, Congiu M, Mazza D, Pescarmona E, Vocaturo A, Benevolo M. Performance of the linear array HPV genotyping test on paired cytological and formalin-fixed, paraffin-embedded cervical samples. J Mol Diagn. 2013. 15: 373-379. https://doi.org/10.1016/j.jmoldx.2013.01.002
  7. Gravitt E, Van doorn J, Quint W, Schiffman M, Hildesheim A, Glass G, Rush B, Hellman J, Sherman E, Burk D, Wang S. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol. 2007. 45: 3245-3250. https://doi.org/10.1128/JCM.00216-07
  8. Ho Y, Burk D, Klein S, Kadish S, Chang J, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995. 87: 1365-1371. https://doi.org/10.1093/jnci/87.18.1365
  9. Kim GH, Kim SH, Park SJ, Park SJ, Han L, Yubo R, Li Y, Lee IS, Lee JD, Lee DS. Human papillomavirus prevalence and distribution according to age among korean and chinese women. Korean J Clin Lab Sci. 2015. 47: 259-266. https://doi.org/10.15324/kjcls.2015.47.4.259
  10. Kim SH, Lee DS, Kim Y, Kim GH, Park SJ, Choi YI, Kim TU, Park KW, Lee HY. Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer. Biomedical Science Letters. 2012. 18: 123-130.
  11. Kim YG, Seo CW, Kim SH, Park YP. Analysis of telomerase activity by HPV E6/E7 expression in SW13. Korean J Clin Lab Sci. 2007. 39: 1-6.
  12. Lee DS, Kim GH, Kim SH, Park SY, Wang HY, Park SJ, Lin H, Ren Y, Yingxue L, Park KW, Lee HY. Human papillomavirus distribution among women in western shandong province, east china using reverse blot hybridization assay. Biomedical Science Letters. 2015. 21: 32-39. https://doi.org/10.15616/BSL.2015.21.1.32
  13. Lee KE. Down-regulation of miR-34a expression in cervical intraepithelial neoplasia with human papillomavirus infection and its relationship with p53 expression. Biomedical Science Letters. 2013. 19: 348-352.
  14. Lee YJ, Jung JH, Park SJ, Jung DY. The relationship between papanicolaou smear test and human papilloma virus DNA chip test in the uterine cervix. Korean J Clin Lab Sci. 2011. 43: 26-32.
  15. Mehlhorn G, Obermann E, Negri G, Bubendorf L, Mian C, Koch M, Sander H, Simm B, Lutge M, Banrevi Z, Weiss A, Cathomas G, Hilfrich R, Wilhelm M, Griesser H. HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study. Mod Pathol. 2013. 26: 967-974. https://doi.org/10.1038/modpathol.2012.233
  16. Munkhdelger J, Choi Y, Lee D, Kim S, Kim G, Park S, Choi E, Jin H, Jeon Y, Lee H, Park H. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Diagn Microbiol Infect Dis. 2014. 79: 422-427. https://doi.org/10.1016/j.diagmicrobio.2014.04.004
  17. Munoz N, Bosch X, De S, Herrero R, Castellsague X, Shah V, Snijders J, Meijer J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003. 348: 518-527. https://doi.org/10.1056/NEJMoa021641
  18. Munoz N, Castellsague X, De B, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006. 24 Suppl 3: S3/1-10.
  19. Oh K, Alemany L, Suh I, Rha H, Munoz N, Bosch X, Quint W, Lloveras B, Klaustermeier E, De sanjose S, Shin R. Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004. Asian Pac J Cancer Prev. 2010. 11: 993-1000.
  20. Quek C, Lim K, Domingo E, Soon R, Park S, Vu V, Tay H, Le T, Kim T, Vu Q, Cao T, Limson G, Pham T, Molijn A, Ramakrishnan G, Chen J. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in asia. International Journal of Gynecological Cancer. 2013. 23: 148-156. https://doi.org/10.1097/IGC.0b013e31827670fd
  21. Rodriguez L, Soveral I, Steenbergen D, Torne A, Martinez S, Fuste P, Pahisa J, Marimon L, Ordi J, Del M. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. BJOG. 2015. 122: 119-127. https://doi.org/10.1111/1471-0528.13071
  22. Tay K, Tay K. The impact of cytology screening and HPV vaccination on the burden of cervical cancer. Asia Pac J Clin Oncol. 2011. 7: 154-159. https://doi.org/10.1111/j.1743-7563.2011.01396.x
  23. Tjalma A, Depuydt E. Cervical cancer screening: which HPV test should be used--L1 or E6/E7? Eur J Obstet Gynecol Reprod Biol. 2013. 170: 45-46. https://doi.org/10.1016/j.ejogrb.2013.06.027
  24. Tjalma A, Fiander A, Reich O, Powell N, Nowakowski M, Kirschner B, Koiss R, O'leary J, Joura A, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De souza C, Jenkins D, Holl K. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer. 2013. 132: 854-867. https://doi.org/10.1002/ijc.27713
  25. Wang Y, Park S, Kim S, Lee D, Kim G, Kim Y, Park H, Lee H. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am J Clin Pathol. 2015. 143: 344-351. https://doi.org/10.1309/AJCPF2XGZ2XIQYQX
  26. Wheeler M. HPV genotypes: implications for worldwide cervical cancer screening and vaccination. Lancet Oncol. 2010. 11: 1013-1014. https://doi.org/10.1016/S1470-2045(10)70249-7